Prabhakunj Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
as on 10-07-2024
- Paid Up Capital ₹ 0.10 M
as on 10-07-2024
- Company Age 7 Year, 5 Months
- Last Filing with ROC 31 Mar 2023
- Revenue 349.79%
(FY 2022)
- Profit 81.36%
(FY 2022)
- Ebitda -9980.67%
(FY 2022)
- Net Worth -15.49%
(FY 2022)
- Total Assets 391.08%
(FY 2022)
About Prabhakunj Pharmaceuticals
The Corporate was formerly known as Prabhakunj Infra Private Limited. The Company is engaged in the Business Services Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Jiral Patel and Mohan Choudhary serve as directors at the Company.
- CIN/LLPIN
U51100GJ2017PTC097059
- Company No.
097059
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
24 Apr 2017
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Navsari, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Prabhakunj Pharmaceuticals?
Board Members(2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jiral Patel  | Director | 24-Apr-2017 | Current |
| Mohan Choudhary | Director | 18-Sep-2021 | Current |
Financial Performance and Corporate Structure Insights of Prabhakunj Pharmaceuticals.
Prabhakunj Pharmaceuticals Private Limited, for the financial year ended 2022, experienced significant growth in revenue, with a 349.79% increase. The company also saw a substantial improvement in profitability, with a 81.36% increase in profit. The company's net worth observed a substantial decline by a decrease of 15.49%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Prabhakunj Pharmaceuticals?
Unlock access to Prabhakunj Pharmaceuticals's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Related Corporates (Common Directorship)
7 years 7 months Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Prabhakunj Pharmaceuticals?
Unlock and access historical data on people associated with Prabhakunj Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Prabhakunj Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Prabhakunj Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
